| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |